Unintended benefits: the potential economic impact of addressing risk factors to prevent Alzheimer's disease.

Certain chronic conditions appear to be modifiable risk factors of Alzheimer's disease and related dementias. To understand the potential health and economic impacts of addressing those risk factors, we used data on a Medicare cohort to simulate four scenarios: a 10 percent reduction in the prevalence of diabetes, hypertension, cardiovascular diseases, respectively, and a 10 percent reduction in body mass index among beneficiaries who were overweight or obese. Our simulation demonstrated that reducing the prevalence of these conditions may yield "unintended benefits" by lowering the risk, delaying the onset, reducing the duration, and lowering the costs of dementia. More research is needed to clarify the exact relationship between various other chronic diseases and dementia. However, our findings highlight potential health gains and savings opportunities stemming from the better management of other conditions associated with dementia.

[1]  Lewis E Kazis,et al.  Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease , 2007, BMC medicine.

[2]  A. Jefferson,et al.  Blood pressure and cognition among older adults: a meta-analysis. , 2013, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[3]  A. Atherly,et al.  A longitudinal analysis of the lifetime cost of dementia. , 2012, Health services research.

[4]  S Jay Olshansky,et al.  Substantial health and economic returns from delayed aging may warrant a new focus for medical research. , 2013, Health affairs.

[5]  R. Petersen,et al.  Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease , 2013, Alzheimer's & Dementia.

[6]  Hilkka Soininen,et al.  Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study , 2006, The Lancet Neurology.

[7]  C. Bulpitt,et al.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.

[8]  S. Gauthier,et al.  Prevention strategies for Alzheimer’s disease , 2012, Translational Neurodegeneration.

[9]  K. Langa,et al.  Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study , 2007, Neuroepidemiology.

[10]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[11]  N. Milas,et al.  Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II , 2001, Annals of Internal Medicine.

[12]  Jaakko Tuomilehto,et al.  The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002 .

[13]  Zhou Yang,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[14]  D. Sparks,et al.  Reduced risk of incident AD with elective statin use in a clinical trial cohort. , 2008, Current Alzheimer research.

[15]  K Yaffe,et al.  Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.

[16]  J D Kalbfleisch,et al.  Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study , 2008, Neurology.

[17]  W. Katon,et al.  Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. , 2013, The lancet. Diabetes & endocrinology.

[18]  W. Song,et al.  Molecular links between Alzheimer’s disease and diabetes mellitus , 2013, Neuroscience.

[19]  A. Hall,et al.  The financial burden of overweight and obesity among elderly Americans: the dynamics of weight, longevity, and health care cost. , 2007, Health services research.

[20]  H. Kuo,et al.  Diabetes and the Risk of Multi-System Aging Phenotypes: A Systematic Review and Meta-Analysis , 2009, PloS one.

[21]  L. Solberg,et al.  Greater use of preventive services in U.S. health care could save lives at little or no cost. , 2010, Health affairs.

[22]  Sandeep Vijan,et al.  The value of medical spending in the United States, 1960-2000. , 2006, The New England journal of medicine.

[23]  L. Thal.  Prevention of Alzheimer Disease , 2006, Alzheimer disease and associated disorders.

[24]  M. Barcikowska,et al.  The impact of mitochondrial and nuclear DNA variants on late-onset Alzheimer's disease risk. , 2011, Journal of Alzheimer's disease : JAD.

[25]  K. Yaffe,et al.  The projected effect of risk factor reduction on Alzheimer's disease prevalence , 2011, The Lancet Neurology.

[26]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[27]  Joshua T. Cohen,et al.  Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer’s disease and related disorders , 2012, Alzheimer's & Dementia.

[28]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[29]  Federico Girosi,et al.  The benefits of risk factor prevention in Americans aged 51 years and older. , 2009, American journal of public health.

[30]  Richard Kahn,et al.  The impact of prevention on reducing the burden of cardiovascular disease. , 2008, Circulation.

[31]  Qian-Li Xue,et al.  Antihypertensive drugs decrease risk of Alzheimer disease , 2013, Neurology.

[32]  D. Kaufer,et al.  An examination of Alzheimer's disease case definitions using Medicare claims and survey data , 2010, Alzheimer's & Dementia.

[33]  Baoping Shang,et al.  The health and cost consequences of obesity among the future elderly. , 2005, Health affairs.

[34]  Anton P. Porsteinsson,et al.  Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders , 2010, Biological Psychiatry.

[35]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[36]  M. Stampfer,et al.  Cardiovascular disease and Alzheimer's disease: common links , 2006, Journal of internal medicine.

[37]  Truls Østbye,et al.  The accuracy of Medicare claims as an epidemiological tool: the case of dementia revisited. , 2009, Journal of Alzheimer's disease : JAD.

[38]  A. Ciobica,et al.  Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease. , 2011, Psychiatria Danubina.

[39]  L. Tan,et al.  Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors. , 2013, Current Alzheimer research.

[40]  V. Pankratz,et al.  Association of diabetes with amnestic and nonamnestic mild cognitive impairment , 2014, Alzheimer's & Dementia.